you are here:

GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals

BSE Live

Nov 26, 16:00
1697.10 -62.25 (-3.54%)
Volume
AVERAGE VOLUME
5-Day
11,348
10-Day
9,196
30-Day
6,130
14,266
  • Prev. Close

    1759.35

  • Open Price

    1759.35

  • Bid Price (Qty.)

    1697.00 (10)

  • Offer Price (Qty.)

    1708.15 (2)

NSE Live

Nov 26, 15:59
1703.65 -53.70 (-3.06%)
Volume
AVERAGE VOLUME
5-Day
247,520
10-Day
175,057
30-Day
101,698
194,037
  • Prev. Close

    1757.35

  • Open Price

    1750.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1703.65 (158)

Financials

2020 2019 2018 2017 2016
Cash Flow of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.) Mar 21 Mar 20 Mar 19 Mar 18 Mar 17  
  12 mths 12 mths 12 mths 12 mths 12 mths  
Net Profit/Loss Before Extraordinary Items And Tax 722.33 646.99 658.82 523.79 465.35  
Net CashFlow From Operating Activities 594.87 490.97 411.18 474.77 232.28  
Net Cash Used In Investing Activities 408.15 -63.10 -154.44 -107.01 303.08  
Net Cash Used From Financing Activities -696.14 -427.62 -358.36 -306.63 -510.76  
Foreign Exchange Gains / Losses 0.00 0.00 0.00 0.00 0.00  
Adjustments On Amalgamation Merger Demerger Others 0.00 0.00 0.00 0.00 0.00  
Net Inc/Dec In Cash And Cash Equivalents 306.87 0.25 -101.62 61.12 24.59  
Cash And Cash Equivalents Begin of Year 98.03 97.78 199.40 138.27 113.68  
Cash And Cash Equivalents End Of Year 404.90 98.03 97.78 199.40 138.27  
Source : Dion Global Solutions Limited